No link between viral findings in the prostate and subsequent cancer development

por Bergh, J, Marklund, I, Gustavsson, C, Wiklund, F, Grönberg, H, Allard, A, Alexeyev, O, Elgh, F
Publicado 2007

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study

por Lenner, P, Wiklund, F, Emdin, S O, Arnerlöv, C, Eklund, C, Hallmans, G, Zentgraf, H, Dillner, J
Publicado 1999

Detection of adeno-associated virus type 2 genome in cervical carcinoma

por Zheng, B Y, Li, X D, Wiklund, F, Chowdhry, S, Ångstrom, T, Hallmans, G, Dillner, J, Wallin, K L
Publicado 2006

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk

por Lindmark, F, Zheng, S L, Wiklund, F, Bälter, K A, Sun, J, Chang, B, Hedelin, M, Clark, J, Johansson, J-E, Meyers, D A, Adami, H-O, Isaacs, W, Grönberg, H, Xu, J
Publicado 2005

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

por FitzGerald, L. M., Zhao, S., Leonardson, A., Geybels, M. S., Kolb, S., Lin, D. W., Wright, J. L., Eeles, R., Kote-Jarai, Z., Govindasami, K., Giles, G. G., Southey, M. C., Schleutker, J., Tammela, T. L., Sipeky, C., Penney, K. L., Stampfer, M. J., Gronberg, H., Wiklund, F., Stattin, P., Hugosson, J., Karyadi, D. M., Ostrander, E. A., Feng, Z., Stanford, J. L.
Publicado 2018